Cogent Biosciences Inc. (COGT)
NASDAQ: COGT
· Real-Time Price · USD
11.88
0.17 (1.45%)
At close: Aug 15, 2025, 3:59 PM
11.89
0.08%
After-hours: Aug 15, 2025, 05:29 PM EDT
Cogent Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -284.08M | -269.5M | -255.86M | -242.3M | -227.04M | -212.17M | -192.41M | -177.66M | -157.34M | -148.19M | -140.24M | -125.53M | -109.56M | -91.18M | -72.27M | -58.7M | -89.6M | -80.44M |
Depreciation & Amortization | 4.5M | 4.42M | 4.35M | 4.04M | 3.79M | 3.93M | 3.59M | 3.73M | 6.59M | 6.53M | 5.88M | 5.01M | 1.35M | 199K | 147K | 96K | 170K | 442K |
Stock-Based Compensation | 40.06M | 40.35M | 39.74M | 38.61M | 37.01M | 34.16M | 30.62M | 26.81M | 22.67M | 20.04M | 18.37M | 17.18M | 16.02M | 14.08M | 11.69M | 8.7M | 8.75M | 7.03M |
Other Working Capital | 7.73M | 11.54M | 10.24M | 12.48M | 9.35M | 1.56M | 6.63M | 7.5M | -4.14M | -1.73M | -1.12M | -5.07M | 1.5M | -2.53M | -731K | -1.31M | -2.19M | -4.04M |
Other Non-Cash Items | 236K | -7.18M | -1M | -2.69M | 12.18M | 8.86M | 895K | 2.65M | -6.87M | -6.66M | -136K | 27.1M | 29.16M | 30.62M | 26.5M | 2.32M | 46.44M | 44.97M |
Deferred Income Tax | n/a | n/a | n/a | 7.76M | n/a | n/a | n/a | -7.76M | n/a | n/a | n/a | -24.7M | -24.7M | -24.7M | -24.7M | -23K | -7.49M | -7.49M |
Change in Working Capital | 15.38M | 10.12M | 11.6M | 17.67M | 11.17M | 12.96M | 11.44M | 13.28M | -473K | -2.06M | 751K | -5.81M | 2.51M | 1.17M | 2.02M | 2.4M | -833K | -4.35M |
Operating Cash Flow | -233.61M | -221.77M | -207.79M | -191.28M | -177.27M | -166.64M | -153.62M | -138.96M | -135.43M | -129.82M | -118.64M | -110.01M | -89.68M | -75.73M | -58.76M | -47.35M | -43.51M | -39.32M |
Capital Expenditures | -1.03M | -1.05M | -573K | -813K | -654K | -1.76M | -2.8M | -4.45M | -7.64M | -7.53M | -6.86M | -5.33M | -3.18M | -2.16M | -1.72M | -966K | 197K | 320K |
Cash Acquisitions | n/a | n/a | n/a | -10.8K | 79.61K | 156.01K | 95.03K | -148.13M | -148.22M | -148.29M | -148.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -100.08M | -182.59M | -255.6M | -293.79M | -386.8M | -362.8M | -348.8M | -327.51M | -363.27M | -236.87M | -177.85M | -148.23M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 301.25M | 290.25M | 294.45M | 281.7M | 223.82M | 207.9M | 253.78M | 252.06M | 230M | 180M | 60M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 1.11M | 1.12M | 1.03M | 957.99K | -95.03K | 148.13M | 148.07M | 148.15M | 148.08M | -148.23K | n/a | n/a | n/a | -320K | 8.1M | 8.1M |
Investing Cash Flow | 200.15M | 106.61M | 38.28M | -12.91M | -163.63M | -156.66M | -97.82M | -79.9M | -140.91M | -64.39M | -124.72M | -153.56M | -3.18M | -2.16M | -1.72M | -966K | 8.62M | 8.74M |
Debt Repayment | 47.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 214.19M | 214.19M | 213.83M | 1.78M | 2.78M | 2.88M | 2.97M | 1.86M | 1.85M | 163.87M | 163.56M | 163.24M | 162.31M | 193K | -30K | 47K | 109.92M | 109.98M |
Financial Cash Flow | 72.85M | 25.36M | 214.45M | 214.43M | 214.8M | 377.15M | 163.54M | 163.85M | 163.84M | 163.87M | 163.56M | 201.25M | 200.31M | 38.2M | 37.98M | 122.11M | 231.98M | 232.04M |
Net Cash Flow | 39.38M | -89.8M | 44.94M | 10.23M | -126.1M | 53.85M | -87.91M | -55.01M | -112.5M | -30.35M | -79.8M | -62.32M | 107.46M | -39.69M | -22.51M | 73.47M | 196.76M | 201.13M |
Free Cash Flow | -234.65M | -222.82M | -208.36M | -192.1M | -177.93M | -168.4M | -156.42M | -143.41M | -143.07M | -137.35M | -125.5M | -115.34M | -92.86M | -77.89M | -60.48M | -48.32M | -43.31M | -39M |